La cadena de opciones muestra datos clave de las opciones de acciones de Avinger a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Avinger..

Avinger (NASDAQ:AVGR) Bolsa, Cadena de Opciones

Avinger

Avinger Inc is a United States-based medical device company. It is engaged in designing, manufacturing, and selling image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). The products offered by the firm include Lightbox imaging console, the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and Pantheris, an image-guided atherectomy device which is designed to allow physicians to precisely remove arterial plaque in PAD patients. It manufactures and sells products in the United States and internationally of which it generates the majority of the revenue from the sales made in the United States.

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

APPS

AVGR

BBAI

COHR

DGLY

FORM

MBRX

MTRX

PTIX

RANI

RXRX

SBET

Market Index Target Term Securities Linked To The Dow Jones Industrial Average

SLXN

SWKS

Coherent sorprende con sus resultados trimestrales y dispara sus acciones un 15,5%. ¿Qué otras empresas se mueven en el premercado de EE.UU.?

Acciones de Coherent (COHR) se disparan un 15%; 20 acciones que se mueven en el premercado de EE.UU.

AEHR

ATCH

ATPC

CANG

CHCI

HCWC

LIDR

NMHI

PHIO

PIII

RGNX

RIME

SANG

STAF

URGN

YOSH

Las acciones de KB Home suben 9,1% tras superar expectativas de ganancias. Descubre los mayores ganadores y perdedores del mercado hoy.

Las acciones de KB Home se disparan un 9%; 20 acciones que se mueven en el premercado de EE.UU.

AMPG

BIPC

CHEK

CREV

FDSB

HSDT

KORE

LAES

LIND

NCRA

NEUE

NVNI

RELI

SLGL

TIVC

TLRY

TOVX

Carbon Revolution lidera con un aumento del 62,4% en el premercado. ¿Qué otras acciones destacaron antes de la apertura?

Las acciones de Carbon Revolution (CREV) están subiendo un 62%; 20 acciones que se están moviendo en el premercado

Avinger Inc

<h3>Gainers</h3>
<ul>
<li>Virpax Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRPX#NASDAQ">VRPX</a>) shares increased by 85.7% to $0.54 during Friday's pre-market session. The company's market cap stands at $9.8 million. </li>
<li>Moleculin Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBRX#NASDAQ">MBRX</a>) stock moved upwards by 60.62% to $2.04. The company's market cap stands at $6.8 million. </li>
<li>CNS Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNSP#NASDAQ">CNSP</a>) stock moved upwards by 25.88% to $0.14. The market value of their outstanding shares is at $7.8 million. </li>
<li>Creative Medical Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CELZ#NASDAQ">CELZ</a>) shares increased by 22.44% to $5.62. The market value of their outstanding shares is at $9.8 million. </li>
<li>Certara (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CERT#NASDAQ">CERT</a>) shares rose 15.15% to $16.41. The company's market cap stands at $2.6 billion. </li>
<li>Matinas BioPharma Hldgs (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MTNB#AMEX">MTNB</a>) shares moved upwards by 11.6% to $0.67. The company's market cap stands at $3.4 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>NKGen Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NKGN#NASDAQ">NKGN</a>) stock declined by 21.1% to $0.61 during Friday's pre-market session. The market value of their outstanding shares is at $21.4 million. </li>
<li>ProPhase Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRPH#NASDAQ">PRPH</a>) stock decreased by 20.59% to $0.27. The market value of their outstanding shares is at $8.1 million. </li>
<li>Artiva Biotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARTV#NASDAQ">ARTV</a>) stock fell 14.97% to $3.41. The market value of their outstanding shares is at $82.8 million. </li>
<li>Healthcare Triangle (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCTI#NASDAQ">HCTI</a>) stock decreased by 14.42% to $0.5. The company's market cap stands at $2.8 million. </li>
<li>Tivic Health Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIVC#NASDAQ">TIVC</a>) stock fell 14.37% to $0.65. The market value of their outstanding shares is at $5.3 million. </li>
<li>Avinger (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGR#NASDAQ">AVGR</a>) stock declined by 13.22% to $0.52. The market value of their outstanding shares is at $1.6 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ARTV

CELZ

CERT

CNSP

HCTI

MTNB

NKGN

PRPH

VRPX

12 Health Care Stocks Moving In Friday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Moleculin Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBRX#NASDAQ">MBRX</a>) shares rose 64.4% to $0.69 during Thursday's pre-market session. The company's market cap stands at $2.3 million. </li>
<li>ProPhase Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRPH#NASDAQ">PRPH</a>) shares increased by 41.39% to $0.4. The market value of their outstanding shares is at $11.9 million. </li>
<li>Firefly Neuroscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIFF#NASDAQ">AIFF</a>) stock rose 29.37% to $16.78. The market value of their outstanding shares is at $134.2 million. </li>
<li>Avinger (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGR#NASDAQ">AVGR</a>) shares rose 23.71% to $0.57. The company's market cap stands at $1.8 million. </li>
<li>Tivic Health Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIVC#NASDAQ">TIVC</a>) shares increased by 15.71% to $0.81. The market value of their outstanding shares is at $6.6 million. </li>
<li>Pliant Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLRX#NASDAQ">PLRX</a>) shares rose 15.38% to $3.14. The market value of their outstanding shares is at $190.9 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>West Pharmaceutical Servs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WST#NYSE">WST</a>) shares fell 24.6% to $243.0 during Thursday's pre-market session. The market value of their outstanding shares is at $17.5 billion. As per the news, the Q4 earnings report came out today. </li>
<li>Aditxt (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADTX#NASDAQ">ADTX</a>) shares decreased by 23.69% to $0.07. The company's market cap stands at $5.4 million. </li>
<li>Omega Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OMGA#NASDAQ">OMGA</a>) stock fell 21.08% to $0.21. The market value of their outstanding shares is at $11.3 million. </li>
<li>Carmell (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTCX#NASDAQ">CTCX</a>) shares decreased by 17.57% to $0.24. The company's market cap stands at $7.2 million. </li>
<li>NKGen Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NKGN#NASDAQ">NKGN</a>) shares decreased by 16.73% to $0.7. The market value of their outstanding shares is at $24.7 million. </li>
<li>Windtree Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WINT#NASDAQ">WINT</a>) shares decreased by 16.17% to $0.14. The company's market cap stands at $1.2 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ADTX

AIFF

CTCX

OMGA

PLRX

WINT

12 Health Care Stocks Moving In Thursday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>ProPhase Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRPH#NASDAQ">PRPH</a>) stock moved upwards by 60.6% to $0.45 during Thursday's pre-market session. The market value of their outstanding shares is at $13.6 million. </li>
<li>Avinger (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGR#NASDAQ">AVGR</a>) shares rose 25.01% to $0.58. The market value of their outstanding shares is at $1.8 million. </li>
<li>Tivic Health Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIVC#NASDAQ">TIVC</a>) shares rose 22.74% to $0.86. The market value of their outstanding shares is at $7.1 million. </li>
<li>Aspira Womens Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AWH#NASDAQ">AWH</a>) shares moved upwards by 18.0% to $0.37. The company's market cap stands at $6.4 million. </li>
<li>DIH Holding US (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DHAI#NASDAQ">DHAI</a>) shares increased by 16.54% to $0.71. The company's market cap stands at $24.9 million. </li>
<li>Kairos Pharma (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/KAPA#AMEX">KAPA</a>) shares moved upwards by 13.97% to $1.55. The market value of their outstanding shares is at $21.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Omega Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OMGA#NASDAQ">OMGA</a>) stock decreased by 26.2% to $0.19 during Thursday's pre-market session. The market value of their outstanding shares is at $10.6 million. </li>
<li>NKGen Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NKGN#NASDAQ">NKGN</a>) stock decreased by 21.6% to $0.66. The company's market cap stands at $23.3 million. </li>
<li>Windtree Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WINT#NASDAQ">WINT</a>) shares decreased by 12.06% to $0.15. The market value of their outstanding shares is at $1.3 million. </li>
<li>Ocean Biomedical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCEA#NASDAQ">OCEA</a>) stock declined by 9.79% to $0.16. The company's market cap stands at $5.4 million. </li>
<li>WORK Medical Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOK#NASDAQ">WOK</a>) stock fell 9.1% to $2.2. The company's market cap stands at $32.1 million. </li>
<li>Redhill Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RDHL#NASDAQ">RDHL</a>) stock decreased by 8.93% to $5.1. The market value of their outstanding shares is at $6.5 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

DHAI

KAPA

OCEA

RDHL

Shares of AppLovin Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APP#NASDAQ">APP</a>) rose sharply in today's pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued first-quarter revenue guidance <a href="https://www.benzinga.com/news/earnings/25/02/43676556/applovin-stock-soars-on-q4-earnings-revenue-beat-eps-beat-strong-guidance-and-more">above estimates</a>.
Applovin reported fourth-quarter revenue of $1.37 billion, beating analyst estimates of $1.26 billion, according to Benzinga Pro. The company reported fourth-quarter earnings of $1.73 per share, beating analyst estimates of $1.25 per share.
AppLovin shares jumped 28.9% to $490.10 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Phoenix Motor Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEV#NASDAQ">PEV</a>) gained 81.2% to $0.4570 in pre-market trading after the company said third-quarter revenue jumped 1,557% year-over-year to $4.77 million.</li>
<li>Tivic Health Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIVC#NASDAQ">TIVC</a>) rose 42% to $0.9937 in pre-market trading. Tivic Health Systems shares jumped 198% on Wednesday after the company announced it acquired the exclusive license rights from Statera Biopharma for its Phase III TLR5 agonist entolimod treatment of acute radiation syndrome.</li>
<li>Avinger, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGR#NASDAQ">AVGR</a>) shares jumped 45.6% to $0.6701 in pre-market trading.</li>
<li>MGO Global, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGOL#NASDAQ">MGOL</a>) gained 38.5% to $0.6326 in pre-market trading after dipping 24% on Wednesday.</li>
<li>ProPhase Labs, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRPH#NASDAQ">PRPH</a>) gained 26% to $0.3535 in pre-market following a 7% gain in the previous session.</li>
<li>Dutch Bros Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BROS#NYSE">BROS</a>) shares climbed 24.6% to $80.72 in pre-market trading following better-than-expected fourth-quarter financial results.</li>
<li>Twin Disc, Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TWIN#NASDAQ">TWIN</a>) gained 19.4% to $11.99 in pre-market trading after dipping 10% on Wednesday.</li>
<li>Robinhood Markets, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>) gained 15.6% to $64.72 in pre-market trading after the company reported better-than-expected quarterly financial results.</li>
<li>CEVA, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CEVA#NYSE">CEVA</a>) gained 8.5% to $34.41 in pre-market trading.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Aspen Aerogels, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASPN#NYSE">ASPN</a>) shares fell 30.6% to $8.15 in pre-market trading after the company issued first-quarter guidance below estimates.</li>
<li>The Trade Desk, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTD#NASDAQ">TTD</a>) dipped 27% to $89.34 in pre-market trading after the company reported worse-than-expected quarterly revenue results.</li>
<li>Omega Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OMGA#NASDAQ">OMGA</a>) fell 24.6% to $0.1960 in today's pre-market trading after surging 35% on Wednesday. Omega Therapeutics' restructuring committee recently approved a workforce reduction of up to 17 employees for cost-reduction amid a Chapter 11 case and potential asset sale.</li>
<li>NKGen Biotech, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NKGN#NASDAQ">NKGN</a>) shares fell 24.4% to $0.6363 in pre-market trading. NKGen Biotech shares jumped 122% on Wednesday after the company received FDA Fast Track designation for Troculeucel for the treatment of moderate Alzheimer&#8217;s disease.</li>
<li>Mynaric AG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYNA#NASDAQ">MYNA</a>) fell 23.7% to $0.4730 in pre-market trading after jumping 134% on Wednesday.</li>
<li>Fastly, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FSLY#NYSE">FSLY</a>) shares tumbled 20.6% to $8.00 in pre-market trading. Fastly reported a fourth-quarter loss of 3 cents per share, down from earnings of 1 cent per share in the prior year&#8217;s quarter. Quarterly revenue came in at $140.58 million, beating the $138.27 million analyst consensus estimate. Fastly expects first-quarter losses of between 9 cents and 5 cents per share, versus the loss of 1 cent estimate, and revenue in a range of $136 million to $140 million, versus the $137.05 million estimate.</li>
<li>Solaris Resources Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLSR#NYSE">SLSR</a>) declined 18.1% to $3.30 in pre-market trading.</li>
<li>Atai Life Sciences N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATAI#NASDAQ">ATAI</a>) fell 14.5% to $2.1800 in pre-market trading after the company announced the pricing of public offering of common shares.</li>
<li>Reddit, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>) fell 14.1% to $185.94 in pre-market trading after the company reported fourth-quarter results.</li>
<li>Open Lending Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LPRO#NASDAQ">LPRO</a>) shares dipped 13% to $5.02 in pre-market trading.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/02/43655479/top-3-utilities-stocks-that-may-collapse-in-q1">Top 3 Utilities Stocks That May Collapse In Q1</a></li>
</ul>

ASPN

ATAI

BROS

CEVA

FSLY

HOOD

LPRO

MGOL

MYNA

RDDT

SLSR

TWIN

Why AppLovin Shares Are Trading Higher By Around 29%; Here Are 20 Stocks Moving Premarket

<h3>Gainers</h3>
<ul>
<li>Lipella Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIPO#NASDAQ">LIPO</a>) stock moved upwards by 64.9% to $5.03 during Tuesday's pre-market session. The company's market cap stands at $6.0 million. </li>
<li>Ocean Biomedical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCEA#NASDAQ">OCEA</a>) stock moved upwards by 50.47% to $0.22. The market value of their outstanding shares is at $7.7 million. </li>
<li>Third Harmonic Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/THRD#NASDAQ">THRD</a>) stock increased by 20.21% to $5.59. The market value of their outstanding shares is at $251.8 million. </li>
<li>Lixte Biotechnology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIXT#NASDAQ">LIXT</a>) stock increased by 15.78% to $2.64. The company's market cap stands at $5.9 million. </li>
<li>Silexion Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLXN#NASDAQ">SLXN</a>) shares increased by 15.26% to $1.51. The market value of their outstanding shares is at $6.0 million. </li>
<li>CNS Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNSP#NASDAQ">CNSP</a>) shares rose 10.53% to $0.11. The company's market cap stands at $6.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Prelude Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRLD#NASDAQ">PRLD</a>) shares fell 17.4% to $0.9 during Tuesday's pre-market session. The market value of their outstanding shares is at $49.5 million. </li>
<li>Stoke Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STOK#NASDAQ">STOK</a>) shares declined by 11.3% to $9.11. The market value of their outstanding shares is at $482.5 million. </li>
<li>DIH Holding US (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DHAI#NASDAQ">DHAI</a>) stock decreased by 10.75% to $0.61. The market value of their outstanding shares is at $21.5 million. </li>
<li>Biodexa Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BDRX#NASDAQ">BDRX</a>) stock declined by 10.62% to $4.8. The market value of their outstanding shares is at $3.2 million. </li>
<li>Invivyd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVVD#NASDAQ">IVVD</a>) shares fell 9.56% to $1.42. The market value of their outstanding shares is at $169.8 million. </li>
<li>Avinger (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGR#NASDAQ">AVGR</a>) stock declined by 9.0% to $0.44. The company's market cap stands at $1.3 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BDRX

IVVD

LIPO

LIXT

PRLD

STOK

THRD

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Lipella Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIPO#NASDAQ">LIPO</a>) shares increased by 158.9% to $6.68 during Thursday's pre-market session. The market value of their outstanding shares is at $8.0 million. </li>
<li>MBX Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBX#NASDAQ">MBX</a>) stock moved upwards by 29.86% to $14.61. The market value of their outstanding shares is at $488.2 million. </li>
<li>Relmada Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RLMD#NASDAQ">RLMD</a>) shares moved upwards by 25.71% to $0.48. The market value of their outstanding shares is at $14.4 million. </li>
<li>TransCode Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNAZ#NASDAQ">RNAZ</a>) shares rose 25.27% to $11.2. The company's market cap stands at $7.7 million. </li>
<li>Rani Therapeutics Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RANI#NASDAQ">RANI</a>) shares moved upwards by 20.83% to $1.74. The market value of their outstanding shares is at $57.9 million. </li>
<li>Invivyd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVVD#NASDAQ">IVVD</a>) stock increased by 20.37% to $2.54. The market value of their outstanding shares is at $303.8 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Avinger (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGR#NASDAQ">AVGR</a>) shares declined by 28.6% to $0.4 during Thursday's pre-market session. The market value of their outstanding shares is at $1.2 million. </li>
<li>Protagenic Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTIX#NASDAQ">PTIX</a>) shares declined by 27.37% to $0.27. The market value of their outstanding shares is at $1.9 million. </li>
<li>Pasithea Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KTTA#NASDAQ">KTTA</a>) shares declined by 27.01% to $2.0. The company's market cap stands at $2.5 million. </li>
<li>Sensus Healthcare (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRTS#NASDAQ">SRTS</a>) shares decreased by 21.58% to $7.05. The market value of their outstanding shares is at $115.5 million. As per the news, the Q4 earnings report came out yesterday. </li>
<li>X4 Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XFOR#NASDAQ">XFOR</a>) stock fell 16.69% to $0.51. The company's market cap stands at $87.6 million. </li>
<li>Universe Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPC#NASDAQ">UPC</a>) shares fell 15.82% to $0.17. The company's market cap stands at $1.4 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

KTTA

RLMD

RNAZ

SRTS

XFOR

U.S. stocks traded slightly higher this morning, with the Nasdaq Composite gaining around 0.2% on Thursday.
Following the market opening Thursday, the Dow traded up 0.03% to 44,887.97 while the NASDAQ rose 0.20% to 19,731.74. The S&amp;P 500 also rose, gaining, 0.20% to 6,073.57.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/25/02/43493237/jim-cramer-this-health-care-stock-is-a-winner-buy-bitcoin-instead-of-coinbase">Jim Cramer: This Health Care Stock Is A &#8216;Winner,&#8217; Buy Bitcoin Instead Of Coinbase</a>
Leading and Lagging Sectors Consumer staples shares surged by 0.6% on Thursday.
In trading on Thursday, utilities shares fell by 0.5%.
Top Headline
U.S. initial jobless claims increased by 11,000 from the previous week to 219,000 in the final week of January, compared to market estimates of 213,000.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Lipella Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIPO#NASDAQ">LIPO</a>) shares shot up 96% to $5.15 after the company received FDA approval for an expanded access program for LP-310 in oral lichen planus.</li>
<li>Shares of Quantum BioPharma Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QNTM#NASDAQ">QNTM</a>)got a boost, surging 83% to $15.72. Quantum Biopharma licensee Celly Nutrition retained leading New York Investment Bank to advise on capital raise and possible initial public offering following highly positive results from unbuzzd&#x2122; clinical study.</li>
<li>Digital Turbine, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APPS#NASDAQ">APPS</a>) shares were also up, gaining 63% to $4.1285 after the company reported better-than-expected third-quarter financial results and raised its FY25 sales guidance.</li>
</ul>
Equities Trading DOWN
<ul>
<li>ReTo Eco-Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RETO#NASDAQ">RETO</a>) shares dropped 41% to $0.4854. ReTo Eco-Solutions recently announced the receipt of Nasdaq delisting determination.</li>
<li>Shares of Sensus Healthcare, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRTS#NASDAQ">SRTS</a>) were down 31% to $6.20 after the company reported mixed fourth-quarter financial results.</li>
<li>Avinger, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGR#NASDAQ">AVGR</a>) was down, falling 31% to $0.3893.</li>
</ul>
Commodities In commodity news, oil traded up 0.6% to $71.45 while gold traded down 0.4% at $2,880.90.
Silver traded down 1.6% to $32.440 on Thursday, while copper rose 0.1% to $4.4450.
Euro zone
European shares were higher today. The eurozone's STOXX 600 rose 0.7%, Germany's DAX 40 gained 0.8% and France's CAC 40 rose 0.9%. Spain's IBEX 35 Index rose 0.8%, while London's FTSE 100 rose 1.6%.
Asia Pacific Markets
Asian markets closed mostly higher on Thursday, with Japan's Nikkei 225 gaining 0.61%, China's Shanghai Composite Index climbing 1.27%, Hong Kong's Hang Seng Index gaining 1.43% and India's BSE Sensex falling 0.27%.
Economics
<ul>
<li>U.S. initial jobless claims increased by 11,000 from the previous week to 219,000 in the final week of January, compared to market estimates of 213,000.</li>
<li>U.S. unit labor costs rose 3.0% in the fourth quarter following a 0.5% gain in the third quarter.</li>
<li>U.S. nonfarm business sector labor productivity rose by 1.2% in the fourth quarter compared to a revised gain of 2.3% in the previous quarter.</li>
<li>U.S. employers announced job cuts of 49,795 in January up from 38,792 in the previous month.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/02/43527663/wall-streets-most-accurate-analysts-weigh-in-on-3-tech-stocks-delivering-high-dividend-yields-2">Wall Street&#8217;s Most Accurate Analysts Weigh In On 3 Tech Stocks Delivering High Dividend Yields</a></li>
</ul>

Earnings

Equities

Eurozone

Commodities

Intraday Update

QNTM

RETO

Dow Edges Higher; US Weekly Jobless Claims Increase

<h3>Gainers</h3>
<ul>
<li>Lipella Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIPO#NASDAQ">LIPO</a>) shares rose 123.2% to $5.76 during Thursday's pre-market session. The company's market cap stands at $6.9 million. </li>
<li>Invivyd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVVD#NASDAQ">IVVD</a>) shares increased by 25.11% to $2.64. The company's market cap stands at $315.7 million. </li>
<li>Rani Therapeutics Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RANI#NASDAQ">RANI</a>) stock rose 17.36% to $1.69. The market value of their outstanding shares is at $56.2 million. </li>
<li>Silexion Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLXN#NASDAQ">SLXN</a>) stock moved upwards by 13.86% to $1.56. The market value of their outstanding shares is at $6.2 million. </li>
<li>MBX Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBX#NASDAQ">MBX</a>) shares increased by 11.11% to $12.5. The market value of their outstanding shares is at $417.7 million. </li>
<li>Xencor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XNCR#NASDAQ">XNCR</a>) shares increased by 9.01% to $19.1. The company's market cap stands at $1.3 billion. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Avinger (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGR#NASDAQ">AVGR</a>) stock fell 37.5% to $0.35 during Thursday's pre-market session. The company's market cap stands at $1.1 million. </li>
<li>Pasithea Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KTTA#NASDAQ">KTTA</a>) shares decreased by 33.95% to $1.81. The market value of their outstanding shares is at $2.2 million. </li>
<li>Protagenic Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTIX#NASDAQ">PTIX</a>) stock decreased by 21.52% to $0.29. The company's market cap stands at $2.1 million. </li>
<li>Sensus Healthcare (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRTS#NASDAQ">SRTS</a>) stock decreased by 16.58% to $7.5. The company's market cap stands at $122.9 million. The company's, Q4 earnings came out yesterday. </li>
<li>Mustang Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBIO#NASDAQ">MBIO</a>) stock decreased by 14.96% to $2.56. The company's market cap stands at $3.3 million. </li>
<li>Moleculin Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBRX#NASDAQ">MBRX</a>) stock fell 14.3% to $0.85. The company's market cap stands at $2.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

MBIO

XNCR

Shares of Coherent Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COHR#NYSE">COHR</a>) rose sharply in pre-market trading after the company reported <a href="https://www.benzinga.com/quote/COHR/earnings">better-than-expected second-quarter financial results.</a>
Coherent reported quarterly earnings of 95 cents per share which beat the analyst consensus estimate of 69 cents per share.&nbsp; The company reported quarterly sales of $1.44 billion which beat the analyst consensus estimate of $1.37 billion.
Coherent shares jumped 15.5% to $104.04 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>SharpLink Gaming, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBET#NASDAQ">SBET</a>) gained 43.5% to $0.6031 in pre-market trading.</li>
<li>Rani Therapeutics Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RANI#NASDAQ">RANI</a>) rose 28.5% to $1.85 in pre-market trading after the company announced new pharmacokinetic and pharmacodynamic data from a preclinical study evaluating the oral delivery of the glucagon-like peptide-1 receptor agonist semaglutide administered via the RaniPill capsule.</li>
<li>Digital Turbine, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APPS#NASDAQ">APPS</a>) gained 28% to $3.25 in pre-market trading after the company reported better-than-expected third-quarter financial results and raised its FY25 sales guidance.</li>
<li>Digital Ally, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DGLY#NASDAQ">DGLY</a>) gained 20.7% to $0.2560 in pre-market trading after gaining around 4% on Wednesday.</li>
<li>Moleculin Biotech, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBRX#NASDAQ">MBRX</a>) shares jumped 20% to $1.20 in pre-market trading after dipping 20% on Wednesday.</li>
<li>Silexion Therapeutics Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLXN#NASDAQ">SLXN</a>) gained 15.2% to $1.58 in pre-market trading after gaining 10% on Wednesday.</li>
<li>Recursion Pharmaceuticals, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXRX#NASDAQ">RXRX</a>) shares climbed 15% to $9.11 in pre-market trading after the company reported 12 month data from phase 2 study (Sycamore) of REC-994 at International Stroke Conference.</li>
<li>BigBear.ai Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBAI#NYSE">BBAI</a>) gained 10.3% to $7.84. BigBear.Ai shares jumped 45% on Wednesday after the company announced a contract by the DOD&#8217;s chief digital and artificial intelligence office.</li>
<li>Ginkgo Bioworks Holdings, Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DNA#NYSE">DNA</a>) gained 8.4% to $17.74 in pre-market trading after climbing over 14% on Wednesday.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Avinger, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGR#NASDAQ">AVGR</a>) shares fell 29.4% to $0.3950 in pre-market trading.</li>
<li>Skyworks Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWKS#NASDAQ">SWKS</a>) dipped 29.2% to $61.65 in pre-market trading after the company issued second-quarter adjusted EPS guidance below estimates..</li>
<li>FormFactor, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FORM#NASDAQ">FORM</a>) fell 27.7% to $29.78 in today's pre-market trading after the company reported worse-than-expected fourth-quarter adjusted EPS results and issued cirst-quarter guidance below estimates.</li>
<li>Matrix Service Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTRX#NASDAQ">MTRX</a>) shares fell 26.1% to $10.38 in pre-market trading after the company reported second-quarter financial results and cut its FY25 sales guidance below estimates.</li>
<li>Protagenic Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTIX#NASDAQ">PTIX</a>) shares tumbled 19.5% to $0.29 in pre-market trading following a 5% gain on Wednesday.</li>
<li>SunCar Technology Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SDA#NASDAQ">SDA</a>) fell 18.3% to $6.90 in pre-market trading after the company reported the pricing of $50 million follow-on public offering of class a ordinary shares.</li>
<li>Symbotic Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYM#NASDAQ">SYM</a>) fell 16.6% to $25.80 in pre-market trading. Symbotic reported quarterly losses of three cents per share which missed the analyst consensus estimate for losses of two cents. Quarterly revenue of $486.69 million also missed the analyst consensus estimate of $490.98 million.</li>
<li>Universe Pharmaceuticals INC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPC#NASDAQ">UPC</a>) fell 12.4% to $0.18 in pre-market trading after dipping 24% on Wednesday. Universe Pharmaceuticals recently announced a Nasdaq delisting notice.</li>
<li>Mach Natural Resources LP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MNR#NYSE">MNR</a>) declined 6.9% to $16.00 in pre-market trading as the company announced the launch of 12 million common unit offering.</li>
<li>Ford Motor Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) shares dipped 6.1% to $9.40 in pre-market trading. Ford reported upbeat fourth-quarter financial results on Wednesday. Ford said it sees full-year 2025 adjusted EBIT in a range of $7 billion to $8.5 billion, adjusted free cash flow in a range of $3.5 billion to $4.5 billion, and capital spending in a range of $8 billion to $9 billion.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/02/43493237/jim-cramer-this-health-care-stock-is-a-winner-buy-bitcoin-instead-of-coinbase">Jim Cramer: This Health Care Stock Is A &#8216;Winner,&#8217; Buy Bitcoin Instead Of Coinbase</a></li>
</ul>

Why Coherent Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket

<h3>Gainers</h3>
<ul>
<li>Firefly Neuroscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIFF#NASDAQ">AIFF</a>) shares increased by 134.7% to $4.46 during Tuesday's pre-market session. The company's market cap stands at $37.9 million. </li>
<li>Eterna Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ERNA#NASDAQ">ERNA</a>) shares increased by 65.04% to $0.51. The market value of their outstanding shares is at $26.2 million. </li>
<li>P3 Health Partners (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PIII#NASDAQ">PIII</a>) shares moved upwards by 30.29% to $0.28. The company's market cap stands at $45.6 million. </li>
<li>Nexalin Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXL#NASDAQ">NXL</a>) stock increased by 18.72% to $2.98. The company's market cap stands at $39.6 million. </li>
<li>Portage Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRTG#NASDAQ">PRTG</a>) stock rose 17.56% to $5.02. The market value of their outstanding shares is at $5.6 million. </li>
<li>Vaxart (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VXRT#NASDAQ">VXRT</a>) stock moved upwards by 15.94% to $0.83. The market value of their outstanding shares is at $189.9 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Phio Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHIO#NASDAQ">PHIO</a>) stock decreased by 41.8% to $3.84 during Tuesday's pre-market session. The company's market cap stands at $6.6 million. </li>
<li>Agape ATP (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATPC#NASDAQ">ATPC</a>) shares declined by 25.89% to $1.46. The company's market cap stands at $5.8 million. </li>
<li>Avinger (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGR#NASDAQ">AVGR</a>) shares decreased by 23.23% to $0.62. The company's market cap stands at $1.9 million. </li>
<li>Salarius Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLRX#NASDAQ">SLRX</a>) shares decreased by 17.99% to $3.01. The company's market cap stands at $4.3 million. </li>
<li>QuidelOrtho (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QDEL#NASDAQ">QDEL</a>) stock decreased by 16.5% to $37.25. The company's market cap stands at $2.5 billion. </li>
<li>Kairos Pharma (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/KAPA#AMEX">KAPA</a>) shares decreased by 15.5% to $1.8. The market value of their outstanding shares is at $23.1 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ERNA

PRTG

QDEL

SLRX

VXRT

<h3>Gainers</h3>
<ul>
<li>P3 Health Partners (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PIII#NASDAQ">PIII</a>) shares increased by 43.8% to $0.31 during Tuesday's pre-market session. The company's market cap stands at $50.3 million. </li>
<li>Immuron (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMRN#NASDAQ">IMRN</a>) stock increased by 22.33% to $2.41. The market value of their outstanding shares is at $13.7 million. </li>
<li>Co-Diagnostics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CODX#NASDAQ">CODX</a>) shares rose 21.12% to $0.92. The market value of their outstanding shares is at $29.4 million. </li>
<li>Regenxbio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGNX#NASDAQ">RGNX</a>) stock rose 17.26% to $8.15. The company's market cap stands at $403.7 million. </li>
<li>Atara Biotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATRA#NASDAQ">ATRA</a>) stock rose 15.44% to $18.69. The market value of their outstanding shares is at $107.6 million. </li>
<li>Abpro Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABP#NASDAQ">ABP</a>) stock increased by 12.3% to $1.46. The market value of their outstanding shares is at $75.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Phio Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHIO#NASDAQ">PHIO</a>) shares declined by 42.7% to $3.78 during Tuesday's pre-market session. The company's market cap stands at $6.5 million. </li>
<li>Avinger (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGR#NASDAQ">AVGR</a>) shares fell 21.56% to $0.63. The company's market cap stands at $2.0 million. </li>
<li>Agape ATP (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATPC#NASDAQ">ATPC</a>) shares fell 21.32% to $1.55. The company's market cap stands at $6.1 million. </li>
<li>Salarius Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLRX#NASDAQ">SLRX</a>) stock decreased by 21.26% to $2.89. The market value of their outstanding shares is at $4.1 million. </li>
<li>Anitra (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AZTR#AMEX">AZTR</a>) shares decreased by 14.8% to $0.49. The market value of their outstanding shares is at $3.7 million. </li>
<li>GT Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTBP#NASDAQ">GTBP</a>) shares decreased by 12.98% to $2.08. The market value of their outstanding shares is at $4.6 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ATRA

AZTR

CODX

GTBP

IMRN

Shares of KB Home (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KBH#NYSE">KBH</a>) rose sharply in today's pre-market trading after the company posted <a href="https://www.benzinga.com/news/earnings/25/01/42962366/kb-home-q4-earnings-revenue-beat-eps-beat-home-deliveries-up-17-net-orders-soar-and-more">better-than-expected fourth-quarter financial results.</a>
KB Home reported fourth-quarter revenue of $2 billion, beating analyst estimates of $1.99 billion. The U.S. homebuilder reported fourth-quarter earnings of $2.52 per share, beating analyst estimates of $2.39 per share, according to Benzinga Pro.
KB Home shares jumped 9.1% to $69.90 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Nature&#8217;s Miracle Holding Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NMHI#NASDAQ">NMHI</a>) gained 109.7% to $2.37 in pre-market trading. On Monday, Nature&#8217;s Miracle Holding announced up to $29.7 million financing.</li>
<li>Staffing 360 Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STAF#NASDAQ">STAF</a>) gained 82.8% to $4.15 in pre-market trading.</li>
<li>P3 Health Partners Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PIII#NASDAQ">PIII</a>) gained 35% to $0.29 in pre-market trading.</li>
<li>UroGen Pharma Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/URGN#NASDAQ">URGN</a>) rose 26.6% to $12.89 in pre-market trading.</li>
<li>REGENXBIO Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGNX#NASDAQ">RGNX</a>) rose 21.7% to $8.46 in pre-market trading. REGENXBIO and Nippon Shinyaku disclosed exclusive partnership to develop and commercialize RGX-121 and RGX-111 for MPS diseases.</li>
<li>Yoshiharu Global Co. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YOSH#NASDAQ">YOSH</a>) gained 20.2% to $3.39 in pre-market trading. Yoshiharu secures up to $11 million in flexible financing for expansion efforts.</li>
<li>AEye, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIDR#NASDAQ">LIDR</a>) gained 19.2% to $1.55 in pre-market trading after dipping 33% on Monday.</li>
<li>Cango Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CANG#NYSE">CANG</a>) gained 12.3% to $4.79 in pre-market trading after declining 9% on Monday. Cango recently announced a boost in its Bitcoin mining production.</li>
<li>AtlasClear Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATCH#NASDAQ">ATCH</a>) gained 9.4% to $8.18 in pre-market trading following a 5% decline on Monday.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Sangoma Technologies Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SANG#NASDAQ">SANG</a>) fell 40.8% to $4.20 in pre-market trading after declining 3% on Monday.</li>
<li>Comstock Holding Companies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHCI#NASDAQ">CHCI</a>) fell 33.8% to $5.20 in today's pre-market trading. The company announced 3 new leases at Loudoun Station.</li>
<li>Agape ATP Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATPC#NASDAQ">ATPC</a>) shares fell 24.8% to $1.48 in pre-market trading after jumping 56% on Monday.</li>
<li>Healthy Choice Wellness Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCWC#NYSE">HCWC</a>) fell 23.8% to $1.28 in pre-market trading after dipping around 9% on Monday.</li>
<li>SMX (Security Matters) Public Limited Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMX#NYSE">SMX</a>) shares dipped 23.5% to $0.1989 in pre-market trading. SMX shares dipped 35% on Monday after the company announced a 28.5-for-1 reverse stock split.</li>
<li>Avinger, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGR#NASDAQ">AVGR</a>) fell 21.4% to $0.6316 in pre-market trading. Avinger shares jumped 43% on Monday after the company announced it has been granted European patent number EP3322338 titled &#8220;MICRO-MOLDED ANAMORPHIC REFLECTOR LENS FOR IMAGE GUIDED THERAPEUTIC/DIAGNOSTIC CATHETERS&#8221;.</li>
<li>Algorhythm Holdings, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIME#NASDAQ">RIME</a>) dipped 20.5% to $0.0798 in pre-market trading following a 25% decline on Monday.</li>
<li>Phio Pharmaceuticals Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHIO#NASDAQ">PHIO</a>) shares fell 20.5% to $5.25 in pre-market trading. Phio Pharmaceuticals shares jumped over 290% on Monday after the company reported a 100% tumor clearance in two patients in its PH-762 Phase 1b cancer study.</li>
<li>Aehr Test Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEHR#NASDAQ">AEHR</a>) declined 19.3% to $12.90 in pre-market trading after the company reported worse-than-expected financial results for the second quarter on Monday.</li>
<li>FTAI Infrastructure Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIP#NASDAQ">FIP</a>) shares tumbled 12.4% to $7.04 in pre-market trading.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/markets/25/01/42965686/top-2-industrials-stocks-that-may-fall-off-a-cliff-in-january">Top 2 Industrials Stocks That May Fall Off A Cliff In January</a></li>
</ul>

Why KB Home Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket

WIIM

Avinger shares are trading higher after the company announced it has been granted European patent number EP3322338 titled "MICRO-MOLDED ANAMORPHIC REFLECTOR LENS FOR IMAGE GUIDED THERAPEUTIC/DIAGNOSTIC CATHETERS".

<a href="https://register.epo.org/application?number=EP16825136" title="https://register.epo.org/application?number=EP16825136">https://register.epo.org/application?number=EP16825136</a>

Biotech

General

Avinger Has Been Granted European Patent Number EP3322338 Titled "MICRO-MOLDED ANAMORPHIC REFLECTOR LENS FOR IMAGE GUIDED THERAPEUTIC/DIAGNOSTIC CATHETERS".

Wall Street experienced a <a href="https://www.benzinga.com/news/treasuries/24/12/42674886/santa-rally-kicks-off-on-wall-street-stocks-gain-tesla-soars-bitcoin-hits-98000">positive start to the Santa Rally season</a>, with all major indices and sectors closing higher in a shortened session ahead of the Christmas holiday. The S&amp;P 500 climbed 1.1%, marking its third consecutive session of gains following last week&#8217;s volatile Federal Reserve meeting. Meanwhile, the tech-heavy Nasdaq 100 gained 1.35%, nearly erasing last week&#8217;s losses. The Dow Jones Industrial Average ended the session higher by 0.9%.
These are the top stocks that gained the attention of retail traders and investors throughout the day.
Tesla Inc. surged 7.35% to close at $462.25, reaching an intraday high of $462.78 and a low of $435.14. The stock has a 52-week high of $488.54 and a low of $138.80. CEO Elon Musk stated that Tesla could <a href="https://www.benzinga.com/24/12/42667044/teslas-valuation-could-exceed-all-transport-companies-but-spacex-ceo-elon-musk">surpass the value</a> of all transport companies except SpaceX, provided there is a lot of work and good ideas.
Avinger Inc. soared 125.72% to $1.45, with an intraday high of $1.93 and a low of $1.01. The stock&#8217;s 52-week high is $5.45, and the low is $0.39. The company said last week that it had <a href="https://www.benzinga.com/24/12/42666807/why-carbon-revolution-shares-are-trading-higher-by-around-62-here-are-20-stocks-moving-premarket">received a Notice of Allowance</a> for a U.S. patent titled "Catheter Device With Detachable Distal End (For The Treatment Of Peripheral Artery Disease)."
Jet.AI Inc. jumped 79.24% to $6.13, hitting an intraday high of $9.99 and a low of $5.85. The stock&#8217;s 52-week high is $607.51, with a low of $3.29. The company launched &#8220;Ava,&#8221; an advanced AI model designed to <a href="https://www.benzinga.com/news/small-cap/24/12/42674451/why-is-jet-ai-stock-trading-over-100-on-tuesday">streamline private jet bookings</a>, which significantly boosted its stock.
Teva Pharmaceutical Industries Limited saw a modest increase of 0.95% to $22.42, with an intraday high of $22.50 and a low of $22.19. The stock&#8217;s 52-week high is $22.50, and the low is $10.34. Stanley Druckenmiller&#8217;s Duquesne Family Office <a href="https://www.benzinga.com/24/12/42668157/stanley-druckenmiller-offloads-streets-hottest-ai-stocks-heres-what-the-billionaire-investor-is-loading-up-on">increased its stake</a> in Teva Pharmaceutical by acquiring over 1.4 million shares in the third quarter.
Netflix Inc. rose 2.27% to $932.12, reaching an intraday high of $935.85 and a low of $911.70. The stock&#8217;s 52-week high is $941.75, with a low of $461.86. Netflix recently <a href="https://www.benzinga.com/24/12/42675098/netflix-takes-vmware-to-court-over-patent-infringement-claims">filed a lawsuit</a> against Broadcom&#8217;s subsidiary VMware over patent infringement, which could impact future operations.
Prepare for the day&#8217;s trading&nbsp;<a href="https://editorial.benzinga.com/wp-admin/Premarket%20Movers%20&amp;%20News">with top premarket movers and news</a>&nbsp;by Benzinga.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42639340/bernie-sanders-is-all-for-canada-becoming-the-51st-state-if-the-u-s-will-also-adopt-universal-healthcare?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Bernie Sanders Is &#8216;All For&#8217; Canada Becoming The 51st State If The U.S. Will Also Adopt Universal Healthcare</a></li>
</ul>
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noreferrer noopener">Shivdeep Dhaliwal</a>

JTAI

NFLX

TEVA

TSLA

Tesla, Avinger, Jet.Ai, Teva, And Netflix: Why These 5 Stocks Are On Investors' Radars Ahead Of Christmas

<h3>Gainers</h3>
<ul>
<li>Avinger (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGR#NASDAQ">AVGR</a>) stock increased by 169.3% to $1.73 during Tuesday's pre-market session. The market value of their outstanding shares is at $5.5 million. </li>
<li>Carmell (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTCX#NASDAQ">CTCX</a>) stock moved upwards by 85.32% to $0.42. The company's market cap stands at $8.7 million. </li>
<li>Tivic Health Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIVC#NASDAQ">TIVC</a>) stock rose 69.47% to $0.38. The market value of their outstanding shares is at $3.1 million. </li>
<li>NeueHealth (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEUE#NYSE">NEUE</a>) shares rose 63.57% to $7.05. The market value of their outstanding shares is at $58.4 million. </li>
<li>180 Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATNF#NASDAQ">ATNF</a>) shares rose 39.03% to $2.6. The company's market cap stands at $5.1 million. </li>
<li>Theriva Biologics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/TOVX#AMEX">TOVX</a>) shares increased by 23.07% to $1.6. The market value of their outstanding shares is at $4.4 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>KalVista Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KALV#NASDAQ">KALV</a>) stock fell 20.7% to $7.0 during Tuesday's pre-market session. The company's market cap stands at $345.9 million. </li>
<li>Anebulo Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANEB#NASDAQ">ANEB</a>) shares declined by 16.0% to $1.05. The market value of their outstanding shares is at $27.2 million. </li>
<li>Dogwood Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DWTX#NASDAQ">DWTX</a>) stock declined by 13.61% to $2.35. The company's market cap stands at $3.1 million. </li>
<li>Traws Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRAW#NASDAQ">TRAW</a>) stock fell 12.1% to $11.05. The market value of their outstanding shares is at $33.4 million. </li>
<li>Astria Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATXS#NASDAQ">ATXS</a>) stock fell 11.77% to $8.4. The market value of their outstanding shares is at $474.0 million. </li>
<li>Ocean Biomedical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCEA#NASDAQ">OCEA</a>) stock fell 11.74% to $0.56. The company's market cap stands at $19.6 million. The company's, Q2 earnings came out yesterday. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ANEB

ATNF

ATXS

DWTX

KALV

TRAW

Avinger Shares Halted On Circuit Breaker To The Upside, Stock Now Up 197.3%

Avinger Shares Resume Trading

<a href="https://ppubs.uspto.gov/dirsearch-public/print/downloadBasicPdf/12171407?requestToken=eyJzdWIiOiI5ZDUzYjAzYi03YmNjLTRhZDQtOTI2Zi00MjUzYzIwY2ZkNDYiLCJ2ZXIiOiI2MDMxNmVkZi00ZWIzLTRlMzQtOWRlMS1jNGNlYjhiNmM3ZDEiLCJleHAiOjB9" title="https://ppubs.uspto.gov/dirsearch-public/print/downloadBasicPdf/12171407?requestToken=eyJzdWIiOiI5ZDUzYjAzYi03YmNjLTRhZDQtOTI2Zi00MjUzYzIwY2ZkNDYiLCJ2ZXIiOiI2MDMxNmVkZi00ZWIzLTRlMzQtOWRlMS1jNGNlYjhiNmM3ZDEiLCJleHAiOjB9">https://ppubs.uspto.gov/dirsearch-public/print/downloadBasicPdf/12171407?requestToken=eyJzdWIiOiI5ZDUzYjAzYi03YmNjLTRhZDQtOTI2Zi00MjUzYzIwY2ZkNDYiLCJ2ZXIiOiI2MDMxNmVkZi00ZWIzLTRlMzQtOWRlMS1jNGNlYjhiNmM3ZDEiLCJleHAiOjB9</a>

Avinger Awarded U.S. Patent 'US 12171407 B2' For 'ATHERECTOMY CATHETER DRIVE ASSEMBLIES'

Avinger Shares Halted On Circuit Breaker To The Upside, Stock Now Up 164.6%

Legal

Press Releases

Avinger Announces Pricing of up to $24 Million Public Offering

Avinger Announces Closing of up to $24 Million Public Offering

Avinger to Announce Second Quarter 2024 Results on August 8, 2024

Avinger Appoints Thomas P. Davis, MD, FACC as Chief Medical Officer

Avinger Reports Second Quarter 2024 Results

Avinger Initiates Full Commercial Launch of Pantheris LV Image-Guided Atherectomy Device

Avinger Announces Issuance of New U.S. Patent and Receives Notices of Allowance for Five Additional U.S. Patents

Avinger Releases Updated Data From IMAGE-BTK in Webinar Featuring Key Opinion Leaders in the Field of Vascular Intervention

Avinger to Announce Third Quarter 2024 Results on November 7, 2024

Avinger Reports Third Quarter 2024 Results

HC Wainwright & Co.

B. Riley Securities

Comments

Avinger

Avinger (AVGR) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL